|
CUL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58409999995168E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.80709999999729E-05 |
| Normal-vs-Stage2 |
1.861360E-03 |
| Normal-vs-Stage3 |
1.68530999999916E-05 |
| Normal-vs-Stage4 |
2.1407999994949E-07 |
| Stage1-vs-Stage2 |
9.325000E-01 |
| Stage1-vs-Stage3 |
2.651400E-01 |
| Stage1-vs-Stage4 |
4.394100E-02 |
| Stage2-vs-Stage3 |
4.274000E-01 |
| Stage2-vs-Stage4 |
1.424230E-01 |
| Stage3-vs-Stage4 |
4.008800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.97809999952825E-07 |
| Normal-vs-AfricanAmerican |
5.615300E-03 |
| Normal-vs-Asian |
8.237000E-04 |
| Caucasian-vs-AfricanAmerican |
5.642000E-01 |
| Caucasian-vs-Asian |
6.019600E-01 |
| AfricanAmerican-vs-Asian |
8.681600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5003599999952E-05 |
| Normal-vs-Female |
3.93060000003498E-06 |
| Male-vs-Female |
5.846400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.028800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.68239999998043E-06 |
| Normal-vs-Age(61-80Yrs) |
5.96609999999886E-05 |
| Normal-vs-Age(81-100Yrs) |
1.431580E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.066800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.638400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.684600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.806200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.603600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.410600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.943400E-01 |
| Classical-VS-Follicular |
8.870000E-01 |
| Classical-VS-Other |
4.033000E-01 |
| Classical-VS-Normal |
4.03220000000371E-06 |
| Tall-VS-Follicular |
9.304600E-01 |
| Tall-VS-Other |
4.719800E-01 |
| Tall-VS-Normal |
3.961500E-03 |
| Follicular-VS-Other |
5.515000E-01 |
| Follicular-VS-Normal |
4.007000E-04 |
| Other-VS-Normal |
1.149570E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07809999999142E-05 |
| Normal-vs-N1 |
4.82679999969093E-07 |
| N0-vs-N1 |
6.013600E-02 |
|
|
